All Columns articles – Page 29
-
-
-
OpinionBeyond buckets and batches
Embracing flow chemistry means leaving behind some faithful friends
-
-
-
BusinessTargeting rare diseases
Is working on genetic mutations that affect only a few in every thousand people risky?
-
-
-
OpinionNatural selection
Bioactive compounds don’t just inspire new synthetic strategies, they’re also the ultimate test
-
Opinion(‒)-Pavidolide B
An innovative approach to making five-membered carbon rings makes for a strikingly short synthesis
-
-
OpinionAre trade sanctions fair?
How much should markets be protected from cheaper imports? When does healthy competition become ‘dumping’?
-
-
OpinionChemistry’s not boring, you’re boring
We said we won’t inspire the next generation with gimmicks - and you’ve responded
-
-
-
OpinionRise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
-
-
